Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

624 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas.
Appenzeller S, Gesierich A, Thiem A, Hufnagel A, Jessen C, Kneitz H, Regensburger M, Schmidt C, Zirkenbach V, Bischler T, Schilling B, Siedel C, Goebeler ME, Houben R, Schrama D, Gehrig A, Rost S, Maurus K, Bargou R, Rosenwald A, Schartl M, Goebeler M, Meierjohann S. Appenzeller S, et al. Among authors: schilling b. Cancer. 2019 Feb 15;125(4):586-600. doi: 10.1002/cncr.31843. Epub 2018 Dec 18. Cancer. 2019. PMID: 30561760 Free article.
Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas.
Griewank KG, Westekemper H, Murali R, Mach M, Schilling B, Wiesner T, Schimming T, Livingstone E, Sucker A, Grabellus F, Metz C, Süsskind D, Hillen U, Speicher MR, Woodman SE, Steuhl KP, Schadendorf D. Griewank KG, et al. Among authors: schilling b. Clin Cancer Res. 2013 Jun 15;19(12):3143-52. doi: 10.1158/1078-0432.CCR-13-0163. Epub 2013 Apr 30. Clin Cancer Res. 2013. PMID: 23633454
Conjunctival melanomas harbor BRAF and NRAS mutations--response.
Griewank KG, Westekemper H, Schilling B, Livingstone E, Schimming T, Sucker A, Hillen U, Steuhl KP, Zimmer L, Schadendorf D. Griewank KG, et al. Among authors: schilling b. Clin Cancer Res. 2013 Nov 15;19(22):6331-2. doi: 10.1158/1078-0432.CCR-13-2368. Epub 2013 Oct 29. Clin Cancer Res. 2013. PMID: 24170549 No abstract available.
Oncogene status as a diagnostic tool in ocular and cutaneous melanoma.
Griewank KG, Schilling B, Scholz SL, Metz CH, Livingstone E, Sucker A, Möller I, Reis H, Franklin C, Cosgarea I, Hillen U, Steuhl KP, Schadendorf D, Westekemper H, Zimmer L. Griewank KG, et al. Among authors: schilling b. Eur J Cancer. 2016 Apr;57:112-7. doi: 10.1016/j.ejca.2016.01.010. Epub 2016 Feb 23. Eur J Cancer. 2016. PMID: 26918736
Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab.
Weide B, Martens A, Hassel JC, Berking C, Postow MA, Bisschop K, Simeone E, Mangana J, Schilling B, Di Giacomo AM, Brenner N, Kähler K, Heinzerling L, Gutzmer R, Bender A, Gebhardt C, Romano E, Meier F, Martus P, Maio M, Blank C, Schadendorf D, Dummer R, Ascierto PA, Hospers G, Garbe C, Wolchok JD. Weide B, et al. Among authors: schilling b. Clin Cancer Res. 2016 Nov 15;22(22):5487-5496. doi: 10.1158/1078-0432.CCR-16-0127. Epub 2016 May 16. Clin Cancer Res. 2016. PMID: 27185375 Free PMC article.
624 results